Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE4

Conditions

NSCLC (Non-small Cell Lung Cancer) · Thyroid Cancer · Solid Tumor Malignancies · Advanced Malignancies

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hospital Universitario San Pedro, Logroño, La Rioja, Spain
Contact: Study coordinator (Maria De Miguel, MD, PhD, MBA) · maria.demiguel@startrioja.com
Hospital Universitario HM Sanchinarro, Madrid, Spain
Contact: Study coordinator (Irene Moreno, MD) · irene.moreno@startmadrid.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

Solid Tumor, Adult · Colorectal Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)Recruiting

Gilbert, United States · Phoenix, United States

A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Cancer · Tumor, Solid · Malignant Neoplasm

Abroad (travel likely)RecruitingPHASE1, PHASE2

Austin, United States · Irving, United States

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE4

Fuzhou, China

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Non-Small Cell Lung Cancer · Exercise Training · Immunotherapy

Abroad (travel likely)Recruiting

Graz, Austria